Back to Search

ELIZABETH POPLIN, MD

MD

Medical Oncology Physician

NPI: 1073698767Individual

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

25MA064963(NJ)25MA06496300(NJ)

Research & Publications (13)

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.
PMID 19581537·J Clin Oncol·2009
3-trial
Pilot study of gemcitabine (10 mg/m(2) per min) and cisplatin.
PMID 12111116·Cancer Chemother Pharmacol·2002
3-trial
A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer.
PMID 18437079·Pancreas·2008
3-trial
"Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
PMID 18095268·J Surg Oncol·2008
5-case
Phase I and pharmacokinetic study of imatinib mesylate (Gleevec) and gemcitabine in patients with refractory solid tumors.
PMID 17908982·Clin Cancer Res·2007
3-trial
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
PMID 17664471·J Clin Oncol·2007
3-trial
Pharmacokinetics of cetuximab after administration of escalating single dosing and weekly fixed dosing in patients with solid tumors.
PMID 17065274·Clin Cancer Res·2006
3-trial
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
PMID 15774775·J Clin Oncol·2005
3-trial
ZD9331 in combination with topotecan: phase I and II experience.
PMID 14567437·Anticancer Drugs·2003
3-trial
A phase I trial of weekly paclitaxel, 13- cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies.
PMID 12768320·Cancer Chemother Pharmacol·2003
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1 ROBERT WOOD JOHNSON PLACE
NEW BRUNSWICK, NJ 08903

Quick Facts

NPI
1073698767
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
13

Are you this provider?

Claim Your Profile